home Go to Doctors Page
  • Products
    • Products A-Z
    • Dry Eye
    • Eye & Whole Body Health
      • OcularProtect® Robust Whole Body Formula
      • OcularEssentials® Whole Body Formula
    • Macular Health Concerns
      • MacularProtect Complete® AREDS-Based Formula & Multinutrient
      • MacularProtect® AREDS-Based Formula
    • Omega-3
    • Optic Nerve Health
    • Retinal Circulation
    • Bone & Joint Health
      • BoneProtect
      • JointProtect
  • Faqs
  • Resources
    • Staying Healthy Newsletter
    • EduFacts Newsletter
    • Product Monographs
    • Educational Links
  • About us
    • Company
    • Advisory Boards
    • Press Releases
    • In the News
    • Events
  • Contact
ScienceBased Health
1 888 433 4726
  • Doctor
  • Consumer
Facebook Twitter

Free Shipping with Auto-Delivery & Savings up to 20% with a Package Plan

more +
Auto-Delivery & Free Shipping!
Save money and add convenience! Your product(s) will be automatically sent to you each month
Select the "Auto Delivery" box at checkout.
Save Packages:
Save up to 20% & Free Shipping!
Purchase 3-5 bottles: save 5%
Purchase 6-11 bottles: save 12%
Purchase 12+ bottles: save 20%

phone

Menu
  • Products
    • Products A-Z
    • Dry Eye
    • Eye & Whole Body Health
      • OcularProtect® Robust Whole Body Formula
      • OcularEssentials® Whole Body Formula
    • Macular Health Concerns
      • MacularProtect Complete® AREDS-Based Formula & Multinutrient
      • MacularProtect® AREDS-Based Formula
    • Omega-3
    • Optic Nerve Health
    • Retinal Circulation
    • Bone & Joint Health
      • BoneProtect
      • JointProtect
  • Faqs
  • Resources
    • Staying Healthy Newsletter
    • EduFacts Newsletter
    • Product Monographs
    • Educational Links
  • About us
    • Company
    • Advisory Boards
    • Press Releases
    • In the News
    • Events
  • Contact
  • Login
  • View Cart
  • (0)
Facebook Twitter

EduFacts Newsletter

Vitamin E Plasma Levels and Early Cortical Lens Opacities

Vitamin E Plasma Levels and Early Cortical Lens Opacities

In an earlier EduFacts (volume 2, number 5) we reviewed data from 2 case control studies published in 1991, which demonstrated a decreased risk of cataract associated with increased intake of vitamin E - α-tocopherol - through diet or use of supplements. A more recent prospective study (published in 1996) was carried out in Finland, evaluating the effect of plasma vitamin E level on the progression of early cortical lens opacities (1).

Methods:

This prospective study was carried out as a sub-study of a population-based prospective clinical trial evaluating pravastatin in middle-aged men with elevated LDL. Of the 447 study participants, 410 completed ophthalmologic exams at baseline and at 18 months and 36 months after baseline. Plasma α-tocopherol concentration was measured at baseline using high performance liquid chromatographic methods. Lens opacity status was determined using the LOCS II system. Progression of lens opacity was defined as an increase in a particular LOCS grade from baseline to 18 months which was verified at the 36 month visit. 742 eyes were evaluated. Both plasma concentration of vitamin E in цmol/L and lipid-standardized plasma vitamin E concentration were evaluated and related to a progression in LOCS score(s). Statistical adjustments for the correlation between the 2 eyes of a single patient were employed. Plasma linoleic acid, certain carbohydrates, vitamin C, and cholesterol were found to be significantly associated with plasma vitamin E. These variables and pravastatin treatment were included in the statistical models as covariates.

Results:

The mean age in this middle-aged male sample was 57.3 years. Mean baseline plasma vitamin E concentration was 28.09 цmol/L (this is slightly higher than the U.S. population mean - see EduFacts volume 3, number 8). Baseline LOCII score distributions in this relatively young age group indicated that 20.2% of eyes had cortical opacity grades of 1 or more; 7.4% had cortical opacity grades of 2 or more. After 3 years of follow-up, baseline plasma vitamin E concentration and lipid-standardized vitamin E were found to be inversely associated with progression of cortical cataract grade.

Relative Risk of Cortical Cataract Progression (1)
(Lowest vs highest quartile level)

 

Relative

95% CI

Plasma vitamin E

3.68

1.15-11.76, p=0.028

Lipid-standardized vitamin E

3.67

1.22-11.09, p=0.021

Plasma vitamin E and lipid standardized vitamin E were not associated with progression of nuclear opacity. The authors point out that in this middle-aged population, the majority of lens opacities at baseline were mild. Thus this study was useful in evaluating the effect of vitamin E levels in the early stages of lens opacity formation and progression. They concluded that in this population low plasma vitamin E concentration was a risk factor for progression of early cortical opacity.

ScienceBased Health's OcularProtect® contains vitamin E and other antioxidants to help protect ocular health.

References

  1. Rouhiainen P, Rouhiainen H, Salonen JT. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. Am J Epidemiol 1996;144:496-500.
Home  >  General Webpages  >  Resources  >  Edufacts Content  >  EduFacts Scientific Write-ups  > 

Stay Informed

Sign up to get nutrition news, health tips, and product updates.

Please also send me:
EduFacts scientific write-ups (monthly)
Notice of new products and special offers

Your information is never shared with third parties. View our privacy policy

Like Us on Facebook

Follow SBH on Facebook for great health tips, product info and much more.

Our Quality Guarantee

  • Products meet or exceed new GMPs
  • Produced in NSF®-certified facilities
  • Highest quality raw materials utilized
  • Third party testing
  • 30-day money-back guarantee (60 days for HydroEye)
Learn more »

More +

Innovative Nutraceuticals for Eye Health

ABOUT SSL
CERTIFICATES

This site chose VeriSign SSL
for secure e-commerce and
confidential communications.

Home | Feedback | Manufacturing | Privacy Policy | Terms & Conditions | Contact Us

Call us Toll Free 1.888.433.4726. From Outside the US and Canada 281.885.7700
©ScienceBased Health

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Top